Compatibility of stabilized whole blood products with CD4 technologies and their suitability for quality assessment programs.

Compatibility of stabilized whole blood products with CD4 technologies and their suitability for quality assessment programs.

BACKGROUND: CD4 T cell enumeration is the most widely used prognostic marker for management of HIV disease. Internal quality control and external quality assessment (EQA) programs are critical to ensure reliability of clinical measurements. The utility of stabilized whole blood products (SWBP) as a...

Full description

Bibliographic Details
Main Authors: Tao Ding, Michèle Bergeron, Peggy Seely, Xuefen Yang, Tamsir O Diallo, Margot Plews, Paul Sandstrom, T Blake Ball, Adrienne F A Meyers
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4126665?pdf=render

Internet

http://europepmc.org/articles/PMC4126665?pdf=render

Similar Items